Benign epilepsy with centrotemporal spikes.

Benign epilepsy with centrotemporal spikes (BECTS) is a common disorder in childhood. After a brief overview of BECTS, a review of the data in favor of treatment with anticonvulsant medications is followed by the data indicating that treatment is not indicated. Some children appear to have cognitive consequences from BECTS. The parents and children with BECTS require a full discussion of the pros and cons of treatment, but based on data available at this time, it is concluded that treatment is generally not indicated for most patients. Future research may lead to changes in the recommendations.

[1]  B. Bourgeois.  Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): a 36-week, double-blind, placebo-controlled study , 1998 .

[2]  J. Wheless,et al.  Benign Rolandic Epilepsy—Perhaps Not So Benign: Use of Magnetic Source Imaging as a Predictor of Outcome , 2008, Journal of child neurology.

[3]  S. Boyd,et al.  Evidence for a neurophysiologic auditory deficit in children with benign epilepsy with centro-temporal spikes , 2006, Journal of Neural Transmission.

[4]  U. Stephani,et al.  The Spectrum from BCECTS to LKS: The Rolandic EEG Trait—Impact on Cognition , 2006, Epilepsia.

[5]  Sanjeev V Thomas,et al.  Educational problems with underlying neuropsychological impairment are common in children with Benign Epilepsy of Childhood with Centrotemporal Spikes (BECTS) , 2005, Seizure.

[6]  S. Boyd,et al.  Language dysfunction in children with Rolandic epilepsy. , 1998, Neuropediatrics.

[7]  J. Dartigues,et al.  Prognosis of Benign Childhood Epilepsy with Centrotemporal Spikes: A Foliow‐Up Study of 168 Patients , 1988, Epilepsia.

[8]  David F. Smith,et al.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial , 2007, The Lancet.

[9]  F. Chiarelli,et al.  Levetiracetam monotherapy for children and adolescents with benign rolandic seizures , 2007, Seizure.

[10]  P. Camfield,et al.  Population study of benign rolandic epilepsy: , 2001, Neurology.

[11]  Thomas Bast,et al.  The Influence of Sulthiame on EEG in Children with Benign Childhood Epilepsy with Centrotemporal Spikes (BECTS) , 2003, Epilepsia.

[12]  A. Bye,et al.  The Neuropsychological and Language Profile of Children with Benign Rolandic Epilepsy , 2005, Epilepsia.

[13]  D. Uluduz,et al.  A Clinical and EEG Study on Idiopathic Partial Epilepsies with Evolution into ESES Spectrum Disorders , 2005, Epilepsia.

[14]  Gregory L. Holmes,et al.  Role of interictal epileptiform abnormalities in cognitive impairment , 2006, Epilepsy & Behavior.

[15]  Howard L McLeod,et al.  Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. , 2008, Pharmacogenomics.

[16]  Tracy Glauser,et al.  ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes , 2006, Epilepsia.

[17]  D. Riva,et al.  Verbal dichotic listening performance and its relationship with EEG features in benign childhood epilepsy with centrotemporal spikes , 2008, Epilepsy Research.

[18]  G. Gobbi,et al.  The Spectrum of Idiopathic Rolandic Epilepsy Syndromes and Idiopathic Occipital Epilepsies: From the Benign to the Disabling , 2006, Epilepsia.

[19]  H. Otsubo,et al.  Malignant rolandic-sylvian epilepsy in children , 2001, Neurology.

[20]  D. Riva,et al.  Intellectual and language findings and their relationship to EEG characteristics in benign childhood epilepsy with centrotemporal spikes , 2007, Epilepsy & Behavior.

[21]  Nobukazu Nakasato,et al.  Opercular to interhemispheric source distribution of benign rolandic spikes of childhood , 2005, NeuroImage.

[22]  U. Stephani,et al.  Atypical “Benign” Partial Epilepsy or Pseudo-Lennox Syndrome. Part I: Symptomatology and Long-Term Prognosis , 2001, Neuropediatrics.

[23]  A. Verrotti,et al.  Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): An open-label, parallel group trial , 2007, Brain and Development.

[24]  T. Panou,et al.  Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: A clinical and cognitive evaluation , 2005, Epilepsy & Behavior.

[25]  M. Cohen,et al.  Cognitive and behavioral problems in children with centrotemporal spikes. , 2000, Pediatric neurology.

[26]  J. Arends,et al.  EEG Characteristics Related to Educational Impairments in Children with Benign Childhood Epilepsy with Centrotemporal Spikes , 2007, Epilepsia.

[27]  Joshua B. Ewen,et al.  Cortical auditory dysfunction in benign rolandic epilepsy , 2008, Epilepsia.

[28]  R. Michelucci,et al.  Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy , 2008, Epilepsia.

[29]  D. Sinclair,et al.  Benign epilepsy of childhood with rolandic spikes: typical and atypical variants. , 2007, Pediatric neurology.

[30]  M. Metz-Lutz,et al.  Neuropsychological Findings in Rolandic Epilepsy and Landau‐Kleffner Syndrome , 2006, Epilepsia.

[31]  L. Nobili,et al.  Neuropsychological disorders related to interictal epileptic discharges during sleep in benign epilepsy of childhood with centrotemporal or Rolandic spikes. , 2001, Developmental medicine and child neurology.

[32]  Josemir W Sander,et al.  Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy , 2007, Drug safety.

[33]  T. Bast,et al.  Sulthiame as Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes: A 6‐Month Randomized, Double‐Blind, Placebo‐Controlled Study , 2000, Epilepsia.

[34]  M Pietsch,et al.  Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures , 1997, Developmental medicine and child neurology.

[35]  C. Hommet,et al.  Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: Rolandic epilepsy and language , 2005, Brain and Language.

[36]  A. Bye,et al.  Memory and phonological awareness in children with Benign Rolandic Epilepsy compared to a matched control group , 2007, Epilepsy Research.

[37]  E. Wirrell,et al.  Deterioration in Cognitive Function in Children With Benign Epilepsy of Childhood With Central Temporal Spikes Treated With Sulthiame , 2008, Journal of child neurology.

[38]  E. Kossoff,et al.  A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy , 2007, Epilepsy & Behavior.

[39]  N. Fejerman,et al.  Atypical Evolutions of Benign Localization‐Related Epilepsies in Children: Are They Predictable? , 2000, Epilepsia.

[40]  Michael Koutroumanidis,et al.  Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. , 2008, Brain : a journal of neurology.

[41]  G. Tedrus,et al.  Epileptiform EEG discharges in benign childhood epilepsy with centrotemporal spikes: Reactivity and transitory cognitive impairment , 2007, Epilepsy & Behavior.

[42]  R. Borgatti,et al.  Academic performance in children with rolandic epilepsy , 2008 .

[43]  G. Tremont,et al.  High Risk of Reading Disability and Speech Sound Disorder in Rolandic Epilepsy Families: Case–Control Study , 2007, Epilepsia.

[44]  C. Tassinari,et al.  Antiepileptic Drug Treatment of Benign Childhood Epilepsy with Rolandic Spikes: Is It Necessary? , 1990, Epilepsia.

[45]  B. Bourgeois.  Determining the Effects of Antiepileptic Drugs on Cognitive Function in Pediatric Patients With Epilepsy , 2004, Journal of child neurology.

[46]  C. Tassinari,et al.  Cognition and Paroxysmal EEG Activities: From a Single Spike to Electrical Status Epilepticus during Sleep , 2006, Epilepsia.